|9.16 0.05 (0.55%)||12-05 16:00|
|Targets||6-month :||10.78||1-year :||12.59|
|Resists||First :||9.23||Second :||10.78|
|Supports||First :||7.66||Second :||6.69|
|MAs||MA(5) :||8.99||MA(20) :||8.65|
|MA(100) :||7.83||MA(250) :||7.83|
|MACD||MACD :||0.3||Signal :||0.3|
|%K %D||K(14,3) :||92.7||D(3) :||90.9|
|52-week||High :||9.52||Low :||5.59|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ MIR ] has closed above the upper band by 0.1%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 37.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|If tomorrow:||Open lower||Open higher|
|High:||9.25 - 9.28||9.28 - 9.32|
|Low:||8.92 - 8.96||8.96 - 9|
|Close:||9.09 - 9.16||9.16 - 9.22|
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, and Japan. It operates through two segments, Medical and Industrial. The medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Industrial segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.
|Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
|Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
|Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
|Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
|Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
|Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Specialty Industrial Machinery
|Shares Out||218 (M)|
|Shares Float||148 (M)|
|Held by Insiders||0.5 (%)|
|Held by Institutions||85.7 (%)|
|Shares Short||7,770 (K)|
|Shares Short P.Month||7,250 (K)|
|EPS Est Next Qtrly||0|
|EPS Est This Year||0|
|EPS Est Next Year||0|
|Book Value (p.s.)||7.42|
|Profit Margin||-29.9 %|
|Operating Margin||-5.6 %|
|Return on Assets (ttm)||-0.7 %|
|Return on Equity (ttm)||-15.7 %|
|Qtrly Rev. Growth||18.7 %|
|Gross Profit (p.s.)||1.45|
|Sales Per Share||3.61|
|Qtrly Earnings Growth||0 %|
|Operating Cash Flow||53 (M)|
|Levered Free Cash Flow||87 (M)|
|Price to Book value||1.23|
|Price to Sales||2.53|
|Price to Cash Flow||37.38|
|Dividend Pay Date||Invalid DateTime.|
|Ex-Dividend Date||Invalid DateTime.|